Kindeva Drug Delivery, a provider of drug-device combination products, has announced the acquisition of Summit Biosciences, an intranasal drug-delivery contract development and manufacturing organisation (CDMO).
NovaBay Pharmaceuticals has announced plans to launch a new cream specifically formulated for psoriasis.
Bavarian Nordic has received an order from the Swiss Armed Forces and the Swiss Federal Office of Public Health for its Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox and monkeypox vaccine doses.
Bavarian Nordic has signed a supply agreement with the Pan American Health Organization (PAHO) for its monkeypox vaccine.
Eli Lilly and Company has announced that its Taltz (ixekizumab) 80mg/mL injection is now available in a new, citrate-free formulation.
Bavarian Nordic has received an order from the US Biomedical Advanced Research and Development Authority (BARDA) for additional doses of Jynneos, a non-replicating vaccine against smallpox and monkeypox.
The US Biomedical Advanced Research and Development Authority (BARDA) has ordered additional doses of Bavarian Nordic’s Jynneos, a non-replicating vaccine to prevent smallpox and monkeypox.
Biopharmaceutical firm Axsome Therapeutics has signed a definitive agreement with Jazz Pharmaceuticals to acquire Sunosi (solriamfetol), in a deal valued at $53m.
Altamira Therapeutics has signed an exclusive licensing and distribution agreement with Nuance Pharma for its nasal spray, Bentrio (AM-301), in Chinese Mainland, Hong Kong, Macau and South Korea.
Merck and its partner Ridgeback Biotherapeutics have received an order from the UK Government to supply an additional 1.75 million patient courses of investigational Covid-19 oral antiviral drug molnupiravir (MK-4482).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.